Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $182.94 million. The enterprise value is $96.43 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRDF has 66.52 million shares outstanding. The number of shares has increased by 18.88% in one year.
Current Share Class | 66.52M |
Shares Outstanding | 66.52M |
Shares Change (YoY) | +18.88% |
Shares Change (QoQ) | +22.70% |
Owned by Insiders (%) | 2.01% |
Owned by Institutions (%) | 36.20% |
Float | 59.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 237.97 |
Forward PS | 454.66 |
PB Ratio | 2.47 |
P/TBV Ratio | 2.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 164.27 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.02.
Current Ratio | 6.22 |
Quick Ratio | 6.04 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.15% and return on invested capital (ROIC) is -48.20%.
Return on Equity (ROE) | -74.15% |
Return on Assets (ROA) | -41.00% |
Return on Invested Capital (ROIC) | -48.20% |
Return on Capital Employed (ROCE) | -72.85% |
Revenue Per Employee | $17,788 |
Profits Per Employee | -$1.48M |
Employee Count | 33 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.54% in the last 52 weeks. The beta is 1.80, so CRDF's price volatility has been higher than the market average.
Beta (5Y) | 1.80 |
52-Week Price Change | -20.54% |
50-Day Moving Average | 3.25 |
200-Day Moving Average | 3.14 |
Relative Strength Index (RSI) | 41.22 |
Average Volume (20 Days) | 1,143,762 |
Short Selling Information
The latest short interest is 17.34 million, so 26.06% of the outstanding shares have been sold short.
Short Interest | 17.34M |
Short Previous Month | 14.81M |
Short % of Shares Out | 26.06% |
Short % of Float | 28.99% |
Short Ratio (days to cover) | 11.79 |
Income Statement
In the last 12 months, CRDF had revenue of $587,000 and -$48.88 million in losses. Loss per share was -$0.92.
Revenue | 587,000 |
Gross Profit | -36.27M |
Operating Income | -52.10M |
Pretax Income | -40.86M |
Net Income | -48.88M |
EBITDA | -51.71M |
EBIT | -52.10M |
Loss Per Share | -$0.92 |
Full Income Statement Balance Sheet
The company has $79.89 million in cash and $1.36 million in debt, giving a net cash position of $78.53 million or $1.18 per share.
Cash & Cash Equivalents | 79.89M |
Total Debt | 1.36M |
Net Cash | 78.53M |
Net Cash Per Share | $1.18 |
Equity (Book Value) | 70.88M |
Book Value Per Share | 1.07 |
Working Capital | 69.42M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -42.75M |
Capital Expenditures | n/a |
Free Cash Flow | -42.75M |
FCF Per Share | -$0.64 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -8,875.64% |
Pretax Margin | -8,322.66% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.88% |
Shareholder Yield | -18.88% |
Earnings Yield | -27.94% |
FCF Yield | -24.43% |
Analyst Forecast
The average price target for CRDF is $12.25, which is 345.46% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.25 |
Price Target Difference | 345.46% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 168.02% |
EPS Growth Forecast (5Y) | 16.48% |
Stock Forecasts Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 0.1666666:1.
Last Split Date | Feb 20, 2019 |
Split Type | Reverse |
Split Ratio | 0.1666666:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |